Få det fulde overblik med HØIBERG Extranet
- Dagligt ajourført overblik over dine immaterielle rettigheder og åbne sager.
- Detaljerede oplysninger om bibliografiske data, frister, udgifter m.m.
- Adgang til sagsakter i form af officieller dokumenter og korrespondence.
- Sikker adgang til data direkte fra Høibergs produktionsdatabase.
- Kontakt HØIBERG hvis du er kunde og ønsker adgang til HØIBERG Extranet.
Updated USPTO Guidelines Regarding Patenting of Products and Laws of Nature & Update on the BRCA1 Patents
19. december 2014
Article written by Jens Viktor Nørgaard
The new guidelines are here and there is cause for cautious optimism
The new guidelines have been expected since early autumn and finally they were issued 16 December 2014. The guidelines are still open for debate and may be changed following public debate and feedback which will take place in January. At the same time there is also news from the US on Myriad Genetics’ attempt to enforce their method-claims against competitors who have started marketing BRCA1 tests following the Supreme Court’s decision that the claims directed to the isolated BRCA1 gene was invalid.
HØIBERG
HØIBERG København
Adelgade 12
DK-1304 København K
Danmark
CVR nr. 38296027
HØIBERG Aarhus
Åbogade 25 A
DK-8200 Aarhus N
Danmark
CVR nr. 38296027
HOIBERG Lund
Mobile Heights Center
Mobilvägen 10
SE-223 62 Lund
Sverige
VAT-nr. SE559058315801
Org. nr.: 559058-3158
Kontakt
Tel. (+45) 33 32 03 37
Fax (+45) 33 32 03 84
hoiberg@hoiberg.com
Kontortid:
Mandag-torsdag: 8.30-16.00
Fredag: 8.30-15.30
Sverige: Kontoret er åbent efter aftale
